<DOC>
	<DOCNO>NCT01948778</DOCNO>
	<brief_summary>Septic shock high mortality risk despite availability various treatment . Endotoxin , present cell wall gram-negative bacteria , potent trigger innate immunity . Endotoxin lead activation cascade overwhelm systemic overflow pro- anti- inflammatory mediator early phase sepsis generalize vascular endothelial damage , tissue injury multi-organ failure . Extracorporeal blood purification therapy aim reduce circulate level endotoxin . Different extracorporeal blood purification system available . The oXiris™ device comprises surface treat AN69 membrane capable adsorb large spectrum plasma cytokine , IL-6 HMGB1 protein . The positively charge inner surface membrane allow absorb negatively charge bacterial product endotoxin . From historical perspective , filter contain AN69-based membrane commonly use product CRRT management critically ill patient substantial volume publish data exist . Another extracorporeal endotoxin removal therapy hemoperfusion ToraymyxinTM ( PMX ) filter , cartridge selectively remove blood endotoxin . PMX compose polymyxin B covalently bond polystyrene-derivative fibre . It well know polarity polymyxin B antibiotic bind endotoxin bactericidal activity . Therefore , rationale underlying extracorporeal therapy PMX remove circulate endotoxin adsorption . - Trial medical device</brief_summary>
	<brief_title>The Effects Polyethyleneimine-coated Membrane ( oXiris™ ) Hemofiltration Versus Polymyxin B- Immobilized Fibre Column ( Toraymyxin™ ) Hemoperfusion Endotoxin Activity Inflammatory Conditions Septic Shock- A Randomized Controlled Pilot Study ( ENDoX-study )</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<criteria>Inclusion criterion : • Patients septic shock , define 30ml/kg i.v . fluid administer within period 6 hour initiation vasopressor therapy vasopressor index =3 , least one follow criterion : metabolic acidosis , neurologic dysfunction , renal dysfunction , acute hepatic dysfunction Male Female patient =18 year Endotoxin level =0.6 IU EAA ( measure ICU admission repeat 24 hour later case initial value =0.4 &lt; 0.6 ) Exclusion criterion : • Endotoxin level &lt; 0.6 IU EAA Pregnancy breast feed Neutropenia ( circulate neutrophil &lt; 500/µl ) Preexisting immune deficiency immunesuppressive therapy , especially corticosteroid Use Vasopressin ( Pitressin ? ) Organ transplantation within last 12 month Terminally ill patient classify `` resuscitate '' History sensitivity polymyxin B anticoagulant ( heparin ) HIT allergy heparin Need extracorporeal membrane oxygenation ( ECMO )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>